Table 2.
Associations between emphysema on computed tomography, percent emphysema, and mortality due to lung disease in the Multi-Ethnic Study of Atherosclerosis, 2000–2013.
| Underlying cause of death | Emphysema on computed tomography (dichotomous) | Percent emphysema (continuous) | ||||
|---|---|---|---|---|---|---|
| Absent (N=6,233) | Present (N=538) | P-value | All (N=6,784) | P-value | ||
| Respiratory diseases | ||||||
| Deaths | 57 | 18 | 77 | |||
| Person-years | 71,845 | 6,078 | 77,750 | |||
| Mortality rate per 10,000 person-years | 7.9 | 29.6 | 9.9 | |||
| Hazard Ratiocrude (95% CI) | 1.00 (referent) | 3.67 (2.16–6.25) | <0.001 | 1.48 (1.35–1.63) | <0.001 | |
| Hazard Ratioadjusted (95% CI) | 1.00 (referent) | 2.94 (1.68–5.15) | <0.001 | 1.51 (1.35–1.69) | <0.001 | |
| Chronic lower respiratory diseases | ||||||
| Deaths | 20 | 17 | 39 | |||
| Person-years | 71,845 | 6,078 | 77,750 | |||
| Mortality rate per 10,000 person-years | 2.8 | 28.0 | 5.0 | |||
| Hazard Ratiocrude (95% CI) | 1.00 (referent) | 10.11 (5.25–19.46) | <0.001 | 1.71 (1.55–1.88) | <0.001 | |
| Hazard Ratioadjusted (95% CI) | 1.00 (referent) | 9.54 (4.70–19.35) | <0.001 | 1.78 (1.57–2.03) | <0.001 | |
| Lung cancer | ||||||
| Deaths | 76 | 19 | 95 | |||
| Person-years | 71,845 | 6,078 | 77,750 | |||
| Mortality rate per 10,000 person-years | 10.6 | 31.3 | 12.2 | |||
| Hazard Ratiocrude (95% CI) | 1.00 (referent) | 2.81 (1.70–4.65) | <0.001 | 1.35 (1.20–1.52) | <0.001 | |
| Hazard Ratioadjusted (95% CI) | 1.00 (referent) | 1.84 (1.09–3.12) | 0.023 | 1.21 (1.06–1.38) | 0.006 | |
| All lung diseases | ||||||
| Deaths | 133 | 37 | 172 | |||
| Person-years | 71,845 | 6,078 | 77,750 | |||
| Mortality rate per 10,000 person-years | 18.5 | 60.9 | 22.1 | |||
| Hazard Ratiocrude (95% CI) | 1.00 (referent) | 3.16 (2.20–4.56) | <0.001 | 1.42 (1.32–1.53) | <0.001 | |
| Hazard Ratioadjusted (95% CI) | 1.00 (referent) | 2.25 (1.54–3.30) | <0.001 | 1.34 (1.23–1.46) | <0.001 | |
The endpoints were defined by an underlying cause of death of respiratory disease (J00–J99), lung cancer (C33–C34) and, combining these, all lung disease. We also specifically examined mortality due to chronic lower respiratory disease (CLRD; J40–47), which was defined as deaths with COPD, emphysema, chronic bronchitis or asthma as the underlying cause, or, in the context of pneumonia as the underlying cause (J12–18), with these diseases (J40–47) recorded as a contributing cause.
For percent emphysema, hazard ratios reported per interquartile range (4.5%), which is equivalent to the difference between the third quartile (5.7%) and the first quartile (1.2%) of percent emphysema. Models adjusted for baseline age, sex, race/ethnicity, body mass index, site, smoking status, pack-years of smoking, coronary artery calcium score, and educational attainment. Upper limit of normal for percent emphysema defined by reference equations.